Showing 621 - 640 results of 3,136 for search '"Diabetes mellitus"', query time: 0.09s Refine Results
  1. 621
  2. 622
  3. 623

    The diabetes mellitus comorbidity index in European Union member states based on the 2019 European Health Interview Survey by Nóra Kovács, Nour Mahrouseh, Lorenzo Monasta, Angela Andreella, Stefano Campostrini, Orsolya Varga

    Published 2025-01-01
    “…Abstract Multiple chronic conditions reduce the quality of life and increase healthcare needs for people with diabetes mellitus (DM). This study aims to describe the prevalence of comorbidities associated with DM in the European Union (EU) at national and sub-national levels and to assess the utility of a comorbidity burden index. …”
    Get full text
    Article
  4. 624

    The Molecular Effects of SGLT2i Empagliflozin on the Autophagy Pathway in Diabetes Mellitus Type 2 and Its Complications by Ranin Saad, Hagar Tadmor, Offir Ertracht, Nakhoul Nakhoul, Farid Nakhoul, Farber Evgeny, Shaul Atar

    Published 2022-01-01
    “…Background. Type 2 diabetes mellitus (T2DM), especially hyperglycemia, is associated with increased glucose cell toxicity and oxidative stress that can lead to irreversible damage in the kidney such as diabetic nephropathy (DN). …”
    Get full text
    Article
  5. 625
  6. 626
  7. 627
  8. 628
  9. 629
  10. 630
  11. 631
  12. 632
  13. 633

    The impact of the novel starch-lipid complexes on the glucolipids metabolism, inflammation, and gut dysbiosis of type 2 diabetes mellitus rats by Yingshuang Lu, Renbing Qin, Jin Wang, Fengjuan Xiang, Yan Zhang, Bowei Zhang, Dancai Fan, Huan Lü, Xuemeng Ji, Shujun Wang, Shuo Wang

    Published 2024-11-01
    “…In this research, we aimed at evaluating the performance of novel starch-lipid complexes, RS5, in comparison with RS2 on physical features, glucolipids metabolism, inflammation, and gut microbiota profiles of type 2 diabetes mellitus (T2DM) rats. The T2DM model was established by streptozotocin injection to the high-fat-sugar fed rats. …”
    Get full text
    Article
  14. 634

    Nitric Oxide Mediates Inflammation in Type II Diabetes Mellitus through the PPARγ/eNOS Signaling Pathway by Hua Guo, Qinglan Zhang, Haipo Yuan, Lin Zhou, Fang-fang Li, Sheng-Ming Wang, Gang Shi, Maojuan Wang

    Published 2020-01-01
    “…Inflammation accounts for the process of type II diabetes mellitus (T2DM), the specific mechanism of which is still to be elucidated yet. …”
    Get full text
    Article
  15. 635
  16. 636
  17. 637

    The protective role of SGLT2 inhibitors on aortic aneurysm mediated by oxidative stress and inflammation in type 2 diabetes mellitus by Rujie Zheng, Wenjuan Song, Jie Lu, Mingyue Yuan, Xiaotong Sun, Chengzhi Lu

    Published 2025-02-01
    “…Abstract Background Sodium-glucose transport protein 2 inhibitors (SGLT2i) have been widely used to treat patients with type 2 diabetes mellitus (T2DM) and have demonstrated protective effects against certain cardiovascular diseases. …”
    Get full text
    Article
  18. 638
  19. 639
  20. 640